New patent for Boehringer Ingelheim drug JENTADUETO March 27, 2024 AutoBot News 0 Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are ten patents… Source